Aperio Group’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | $5.67M | Buy |
45,182
+22,747
| +101% | +$2.85M | 0.02% | 771 |
|
|
2020
Q3 | $2.28M | Buy |
22,435
+3,264
| +17% | +$331K | 0.01% | 1059 |
|
|
2020
Q2 | $1.87M | Buy |
19,171
+1,624
| +9% | +$158K | 0.01% | 1143 |
|
|
2020
Q1 | $1.46M | Buy |
17,547
+2,531
| +17% | +$210K | 0.01% | 1155 |
|
|
2019
Q4 | $1.67M | Buy |
15,016
+121
| +0.8% | +$13.4K | 0.01% | 1176 |
|
|
2019
Q3 | $1.48M | Buy |
14,895
+2,487
| +20% | +$247K | 0.01% | 1195 |
|
|
2019
Q2 | $1.23M | Sell |
12,408
-1,721
| -12% | -$171K | 0.01% | 1301 |
|
|
2019
Q1 | $1.56M | Buy |
14,129
+894
| +7% | +$98.6K | 0.01% | 1149 |
|
|
2018
Q4 | $1.22M | Buy |
13,235
+2,517
| +23% | +$231K | 0.01% | 1204 |
|
|
2018
Q3 | $1.18M | Buy |
10,718
+3,143
| +41% | +$346K | 0.01% | 1314 |
|
|
2018
Q2 | $707K | Buy |
7,575
+1,393
| +23% | +$130K | ﹤0.01% | 1572 |
|
|
2018
Q1 | $513K | Buy |
6,182
+2,134
| +53% | +$177K | ﹤0.01% | 1680 |
|
|
2017
Q4 | $369K | Buy |
4,048
+62
| +2% | +$5.65K | ﹤0.01% | 1845 |
|
|
2017
Q3 | $304K | Buy |
3,986
+886
| +29% | +$67.6K | ﹤0.01% | 1914 |
|
|
2017
Q2 | $233K | Buy |
+3,100
| New | +$233K | ﹤0.01% | 2031 |
|